The controversial Swiss pharmaceutical company Novartis has started work to expand health-care access in low-income countries through its nonprofit Novartis Foundation. The expansion into a role that builds health systems is stirring all kinds of questions.
Despite their wealth and superior access to health care, Europeans are the most skeptical about vaccine safety, according to the…
For today’s Humanosphere podcast, we’re talking with Peter Piot, director of the London School of Hygiene and Tropical Medicine, who…
As the Disneyland measles outbreak in the United States demonstrated – if not the two-to-three million child deaths from easily…
For today’s Humanosphere podcast, we’re talking with Heidi Larson, a professor of anthropology at the London School of Hygiene and…